Chemical inhibitors of H3-K9-HMTase include a variety of compounds that interact with the protein in different ways to reduce its enzymatic activity. Chaetocin is one such inhibitor that directly binds to the active site of H3-K9-HMTase, thereby obstructing the enzyme's ability to transfer methyl groups to the histone H3 lysine 9 residue. Similarly, BIX-01294 competes with both the peptide substrate and the cofactor S-adenosyl methionine (SAM), crucial for the methyl group transfer, which results in diminished methylation activity of the enzyme. UNC0638, although it has higher specificity towards SETDB1 HMTase, inhibits H3-K9-HMTase by preventing the enzyme from interacting with its substrates, thus reducing the histone methylation.
In addition to these direct inhibitors, other compounds can inhibit H3-K9-HMTase activity through different mechanisms. EPZ004777, for instance, can bind to the SAM-binding pocket of H3-K9-HMTase and block the cofactor from participating in the methylation process. IOX1, while primarily an inhibitor of 2-oxoglutarate dependent oxygenases, can increase the methylation mark targeted by H3-K9-HMTase, indirectly reducing its functional activity by limiting the availability of histone demethylation. 3-Deazaneplanocin A (DZNep) depletes cellular levels of SAM, which is indispensable for the methyltransferase action of H3-K9-HMTase. Quinacrine alters chromatin structure through its DNA intercalation, which can inhibit H3-K9-HMTase by making its substrate, the histone, less accessible. Sinefungin competes with SAM for the active site of various methyltransferases, including H3-K9-HMTase, thereby inhibiting the methylation process. Furthermore, DNA methyltransferase inhibitors like Decitabine and RG108 can indirectly affect H3-K9-HMTase by changing the epigenetic landscape and the substrate availability. Lastly, Adenosine dialdehyde increases the levels of S-adenosylhomocysteine, a product inhibitor of SAM-dependent methyltransferases, which can also result in the functional inhibition of H3-K9-HMTase. Each of these chemicals interacts with the enzyme or its associated pathways to inhibit the proper functioning of H3-K9-HMTase, preventing the methylation of histone H3 at the ninth lysine position.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Chaetocin is a known inhibitor of several histone methyltransferases, including H3-K9-HMTase. It specifically inhibits the enzyme by binding to the active site where the methylation reaction occurs, thereby preventing the transfer of methyl groups to the histone H3 lysine 9 residue. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX-01294 is a diazepin-quinazolin-amine derivative that acts as an inhibitor of H3-K9-HMTase by competing with the substrate peptide and the cofactor S-adenosyl methionine (SAM). This leads to a reduction in the methylation activity of H3-K9-HMTase. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 is a potent inhibitor of H3-K9-HMTase with specificity towards the SETDB1 HMTase. It functions by preventing the proper interaction between H3-K9-HMTase and its substrates, thereby inhibiting enzymatic activity on the histone substrate. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
EPZ004777 targets the DOT1L HMTase, but it may also inhibit H3-K9-HMTase by binding to the SAM-binding pocket, preventing SAM from participating in the transfer of methyl groups to the histone H3 lysine 9 position. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Quinacrine is known to intercalate into DNA and may hinder the access of H3-K9-HMTase to its histone substrate by altering chromatin structure, thus functionally inhibiting the enzyme's activity. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Sinefungin is a natural nucleoside that acts as an inhibitor of SAM-dependent methyltransferases, including H3-K9-HMTase. It competes with SAM for binding to the enzyme, which is essential for the methylation process. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a cytidine analog that incorporates into DNA and inhibits DNA methyltransferases. Though its primary target is DNA methylation, by altering the epigenetic landscape, it can indirectly affect H3-K9-HMTase activity by changing the substrate availability. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that, similar to Decitabine, can indirectly impact H3-K9-HMTase activity by modifying the epigenetic state of the cell and potentially altering substrate availability for methylation. | ||||||
Adenosine, periodate oxidized | 34240-05-6 | sc-214510 sc-214510A | 25 mg 100 mg | $119.00 $364.00 | ||
Adenosine dialdehyde is an inhibitor of S-adenosylhomocysteine hydrolase and thereby increases the concentration of S-adenosylhomocysteine, a strong product inhibitor of SAM-dependent methyltransferases including H3-K9-HMTase. | ||||||